Company Management

Lyra Therapeutics

Biotechnology Research Watertown, Massachusetts, United States 41 employees MLTX

Employees: 41
Contacts: 3
Emails: 3

lyratherapeutics.com LinkedIn Crunchbase

Lyra Therapeutics Overview

Headquarters: Watertown, Massachusetts, United States
Phone Number: Available in AeroLeads
Website: lyratherapeutics.com
Industry: Biotechnology Research
Employees: 41
Founded: 2018
Stock Symbol: MLTX
Funding: 5.0M
Company Email: Available in AeroLeads
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Pharmaceuticals and Biotechnology

About Lyra Therapeutics

Lyra Therapeutics is a clinical-stage biotechnology company developing innovative therapies for the localized treatment of chronic rhinosinusitis (CRS), an inflammatory disease of the paranasal sinuses which leads to debilitating symptoms and significant morbidities. Building on expertise in materials science, drug development and formulation, Lyra has developed proprietary technology that is designed to deliver medicines directly precisely and consistently to the affected tissue for sustained periods with a single administration. Our product candidates, LYR-210 and LYR-220, are bioresorbable polymeric matrices designed to be administered in a brief, in-office procedure and intended to deliver up to six months of continuous mometasone furoate drug therapy to the sinonasal passages for the treatment of CRS.

Lyra Therapeutics Contact Details

People in AeroLeads: 4
With contact data: 3
Email contacts: 3; 75.0% coverage

Lyra Therapeutics Org Chart

Sample employees and titles

Name	Title	Location	Contact
Jeff Holmes	Facilities, Engineering, Commissioning	Greater Boston, United States	Email
Jason Cavalier		New York City Metropolitan Area, United States	Email
Maria Palasis	President and CEO, Lyra Therapeutics		View
Ronan O'brien		Greater Boston, United States	Email